BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25653139)

  • 1. Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.
    Kenny HA; Lal-Nag M; White EA; Shen M; Chiang CY; Mitra AK; Zhang Y; Curtis M; Schryver EM; Bettis S; Jadhav A; Boxer MB; Li Z; Ferrer M; Lengyel E
    Nat Commun; 2015 Feb; 6():6220. PubMed ID: 25653139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth.
    Lal-Nag M; McGee L; Guha R; Lengyel E; Kenny HA; Ferrer M
    SLAS Discov; 2017 Jun; 22(5):494-506. PubMed ID: 28346091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.
    Kenny HA; Krausz T; Yamada SD; Lengyel E
    Int J Cancer; 2007 Oct; 121(7):1463-72. PubMed ID: 17546601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis.
    Kenny HA; Lal-Nag M; Shen M; Kara B; Nahotko DA; Wroblewski K; Fazal S; Chen S; Chiang CY; Chen YJ; Brimacombe KR; Marugan J; Ferrer M; Lengyel E
    Mol Cancer Ther; 2020 Jan; 19(1):52-62. PubMed ID: 31562255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
    Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
    Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.
    Mitra AK; Chiang CY; Tiwari P; Tomar S; Watters KM; Peter ME; Lengyel E
    Oncogene; 2015 Nov; 34(48):5923-32. PubMed ID: 25798837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin inhibits the development and metastasis of ovarian cancer.
    Wu B; Li S; Sheng L; Zhu J; Gu L; Shen H; La D; Hambly BD; Bao S; Di W
    Oncol Rep; 2012 Sep; 28(3):903-8. PubMed ID: 22752027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of cantharidin on invasion and metastasis of highly metastatic ovarian carcinoma cell line HO-8910PM].
    He TP; Mo LE; Liang NC
    Ai Zheng; 2005 Apr; 24(4):443-7. PubMed ID: 15820067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Natural Product β-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis.
    Kenny HA; Hart PC; Kordylewicz K; Lal M; Shen M; Kara B; Chen YJ; Grassl N; Alharbi Y; Pattnaik BR; Watters KM; Patankar MS; Ferrer M; Lengyel E
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment.
    Hilliard TS; Kowalski B; Iwamoto K; Agadi EA; Liu Y; Yang J; Asem M; Klymenko Y; Johnson J; Shi Z; Marfowaa G; Yemc MG; Petrasko P; Stack MS
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
    Kenny HA; Chiang CY; White EA; Schryver EM; Habis M; Romero IL; Ladanyi A; Penicka CV; George J; Matlin K; Montag A; Wroblewski K; Yamada SD; Mazar AP; Bowtell D; Lengyel E
    J Clin Invest; 2014 Oct; 124(10):4614-28. PubMed ID: 25202979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.
    Peters PN; Schryver EM; Lengyel E; Kenny H
    J Vis Exp; 2015 Dec; (106):e53541. PubMed ID: 26780294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HTS-compatible 3D colony formation assay to identify tumor-specific chemotherapeutics.
    Horman SR; To J; Orth AP
    J Biomol Screen; 2013 Dec; 18(10):1298-308. PubMed ID: 23918920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of In Vitro Co-Culture Model in Anti-Cancer Drug Development Cascade.
    Xu R; Richards FM
    Comb Chem High Throughput Screen; 2017; 20(5):451-457. PubMed ID: 28155598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.
    Lee JM; Mhawech-Fauceglia P; Lee N; Parsanian LC; Lin YG; Gayther SA; Lawrenson K
    Lab Invest; 2013 May; 93(5):528-42. PubMed ID: 23459371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.
    Mosaad E; Chambers K; Futrega K; Clements J; Doran MR
    BMC Cancer; 2018 May; 18(1):592. PubMed ID: 29793440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
    Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
    Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening.
    Krausz E; de Hoogt R; Gustin E; Cornelissen F; Grand-Perret T; Janssen L; Vloemans N; Wuyts D; Frans S; Axel A; Peeters PJ; Hall B; Cik M
    J Biomol Screen; 2013 Jan; 18(1):54-66. PubMed ID: 22923784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.
    Jabs J; Zickgraf FM; Park J; Wagner S; Jiang X; Jechow K; Kleinheinz K; Toprak UH; Schneider MA; Meister M; Spaich S; Sütterlin M; Schlesner M; Trumpp A; Sprick M; Eils R; Conrad C
    Mol Syst Biol; 2017 Nov; 13(11):955. PubMed ID: 29180611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles.
    Lu M; Henry CE; Lai H; Khine YY; Ford CE; Stenzel MH
    Biomater Sci; 2019 Mar; 7(4):1652-1660. PubMed ID: 30724288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.